Literature DB >> 6421389

Chemotherapy of solid tumours: trials and tribulations.

G M Mead, J M Whitehouse.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6421389      PMCID: PMC1444341          DOI: 10.1136/bmj.288.6417.585

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  11 in total

1.  Randomized comparison of cis-diamminedichloroplatinum versus cis-diamminedichloroplatinum, methotrexate, and bleomycin in recurrent squamous cell carcinoma of the head and neck.

Authors:  S Davis; W Kessler
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

Review 2.  Integration of chemotherapy into a combined modality treatment plan for head and neck cancer: a review.

Authors:  J H Glick; S G Taylor
Journal:  Int J Radiat Oncol Biol Phys       Date:  1981-02       Impact factor: 7.038

3.  Reflections on medical oncology: an appeal for better clinical trials and improved reporting of their results.

Authors:  I Tannock; K Murphy
Journal:  J Clin Oncol       Date:  1983-01       Impact factor: 44.544

4.  Long-term results of VBM and radiotherapy in advanced head and neck cancer.

Authors:  D O'Connor; P Clifford; W G Edwards; V M Dalley; J Durden-Smith; B A Hollis; F M Calman
Journal:  Int J Radiat Oncol Biol Phys       Date:  1982-09       Impact factor: 7.038

5.  Sequential chemotherapy and radiotherapy in advanced head and neck cancer.

Authors:  P M Stell; J E Dalby; P Strickland; J G Fraser; P J Bradley; L M Flood
Journal:  Clin Radiol       Date:  1983-07       Impact factor: 2.350

6.  A prospective randomized trial of methotrexate versus cisplatin in the treatment of recurrent squamous cell carcinoma of the head and neck.

Authors:  W K Hong; S Schaefer; B Issell; C Cummings; D Luedke; R Bromer; S Fofonoff; J D'Aoust; S Shapshay; J Welch; E Levin; M Vincent; C Vaughan; S Strong
Journal:  Cancer       Date:  1983-07-15       Impact factor: 6.860

7.  A randomized trial of the combination of cis-platinum, oncovin and bleomycin (COB) versus methotrexate in patients with advanced squamous cell carcinoma of the head and neck.

Authors:  A Drelichman; G Cummings; M Al-Sarraf
Journal:  Cancer       Date:  1983-08-01       Impact factor: 6.860

8.  Histopathologic findings after cis-platinum bleomycin therapy in advanced previously untreated head and neck carcinoma.

Authors:  S M Shapshay; W K Hong; J S Incze; K Yamaguchi; R Bhutani; C W Vaughan; M S Strong
Journal:  Am J Surg       Date:  1978-10       Impact factor: 2.565

9.  Methotrexate treatment of squamous-cell head and neck cancers: dose-response evaluation.

Authors:  R L Woods; R M Fox; M H Tattersall
Journal:  Br Med J (Clin Res Ed)       Date:  1981-02-21

10.  Failure of short-course multiple drug chemotherapy to benefit patients with recurrent or metastatic head and neck cancer.

Authors:  I Tannock; D Sutherland; D Osoba
Journal:  Cancer       Date:  1982-04-01       Impact factor: 6.860

View more
  1 in total

Review 1.  Cytotoxic chemotherapy for common adult malignancies: "the emperor's new clothes" revisited?

Authors:  J H Kearsley
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.